InvestorsHub Logo
Followers 18
Posts 624
Boards Moderated 0
Alias Born 11/21/2014

Re: None

Monday, 09/14/2020 8:52:46 AM

Monday, September 14, 2020 8:52:46 AM

Post# of 642
IFRX on alert 26m OS 19m float 97m market cap

InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia

PUBLISHED
SEP 14, 2020 7:30AM EDT
First site initiated for enrollment in the Netherlands
Regulatory approval granted to start trial in Germany
Additional sites to be added in the US, EU and other regions
Encouraging Phase II data accepted for publication in The Lancet Rheumatology

*I probably own shares of this stock. All posts are made in my opinion only and are not investing advice.

$RLFTF & $RDHL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IFRX News